PellePharm, Inc. operates in the biotechnology industry. The company was incorporated in 2012 and is based in Menlo Park, California. Focused on the development of topical patidegib, a first-in-class topical hedgehog inhibitor, to decrease the number of surgically-eligible basal cell carcinomas (BCCs) in persons with Gorlin Syndrome and those with sporadic BCCs.
Type
Private
HQ
Menlo Park, US
Founded
2012
Size (employees)
5 (est)
PellePharm was founded in 2012 and is headquartered in Menlo Park, US
Report incorrect company information

Key People/Management at PellePharm

Sanuj Ravindran

Sanuj Ravindran

President, CEO & Director
Ervin Epstein

Ervin Epstein

Co-Founder, Director & Chief Medical Officer, PellePharm
GERD KOCHENDOERFER Ph.D

GERD KOCHENDOERFER Ph.D

Vice President, Technical Operations & Program Management, PellePharm
Alix Alderman

Alix Alderman

Vice President of Regulatory Affairs, PellePharm

PellePharm Office Locations

PellePharm has an office in Menlo Park
Menlo Park, US (HQ)
275 Middlefield Road
Show all (1)
Report incorrect company information

PellePharm Financials and Metrics

Summary Metrics

Founding Date

2012

Total Funding

$11.4 m

Latest funding size

$3.25 m

Time since last funding

2 years ago
PellePharm's latest funding round in August 2016 was reported to be $3.3 m. In total, PellePharm has raised $11.4 m
Show all financial metrics
Report incorrect company information